Clifford Chin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Clifford Chin has a total of 134 co-authors. Here are the top co-authors by number of shared publications:
- Farhan Zafar
Department of Cardiothoracic Surgery, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio
9 shared publications - David Luis Simon Morales
University of Cincinnati College of Medicine
8 shared publications - Adam W. Powell
University of Cincinnati College of Medicine
4 shared publications Angela Lorts
The Heart Institute, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio
4 shared publications- Alexander Reuben Opotowsky
Adult Congenital Heart Disease Program, Heart Institute, Cincinnati Children's Hospital Medical Center
3 shared publications - Hosam F. Ahmed
NYU Langone Health New York City New York USA
3 shared publications
Latest Publications
- 12 October 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (10) , e70475
Exceptions in Pediatric Heart Transplantation: Are We Prioritizing the Right Patients?
Background: In 2018, UNOS changed policies, altering organ distribution patterns. We compare survival in 1A patients with and without exceptions after these policy changes. Methods: Using UNOS, we included Status 1A patients (< 18 years of age) listed for a heart transplant from 2018 to 2025 and categorized them by exception status. Primary outcomes were survival from listing and post‐transplant survival. Multivariable Cox regression assessed the independent association between exception status and survival, with a sub‐analysis restricted to non‐VAD patients. Results: Of the 3993 patients, 835 (21%) were listed by exceptions. Exception patients were older (7 vs. 2 years, p < 0.001), less often congenital heart disease (CHD) (19% vs. 65%, p < 0.001), and less often on ECMO, VAD, or ventilator support at listing (all p < 0.001). Exception patients had lower waitlist mortality (3.5% vs. 9.8%, p < 0.001), improved survival from listing (log‐rank p < 0.0001), and improved post‐transplant survival (log‐rank p < 0.05). After adjustment for age, diagnosis, and pretransplant mechanical and ventilatory support, exception status was associated with superior survival from waitlist (HR 0.760, 95% CI 0.597–0.968, p = 0.026). In the sub analysis of patients who were not on VAD, exception status shows a trend toward improved waitlist survival (HR 0.843, 95% CI 0.652–1.09, p = 0.19). Conclusions: Status 1A exception patients have improved waitlist and unadjusted post‐transplant survival as compared to standard criteria patients, and are, on average, less acutely ill at listings. These findings highlight heterogeneity within Status 1A and suggest an opportunity to incorporate objective acuity measures into exception review.
- 12 October 2026
- Published by Wiley in Pediatric Transplantation
- Vol. 30 (10) , e70475
Exceptions in Pediatric Heart Transplantation: Are We Prioritizing the Right Patients?
Background: In 2018, UNOS changed policies, altering organ distribution patterns. We compare survival in 1A patients with and without exceptions after these policy changes. Methods: Using UNOS, we included Status 1A patients (< 18 years of age) listed for a heart transplant from 2018 to 2025 and categorized them by exception status. Primary outcomes were survival from listing and post‐transplant survival. Multivariable Cox regression assessed the independent association between exception status and survival, with a sub‐analysis restricted to non‐VAD patients. Results: Of the 3993 patients, 835 (21%) were listed by exceptions. Exception patients were older (7 vs. 2 years, p < 0.001), less often congenital heart disease (CHD) (19% vs. 65%, p < 0.001), and less often on ECMO, VAD, or ventilator support at listing (all p < 0.001). Exception patients had lower waitlist mortality (3.5% vs. 9.8%, p < 0.001), improved survival from listing (log‐rank p < 0.0001), and improved post‐transplant survival (log‐rank p < 0.05). After adjustment for age, diagnosis, and pretransplant mechanical and ventilatory support, exception status was associated with superior survival from waitlist (HR 0.760, 95% CI 0.597–0.968, p = 0.026). In the sub analysis of patients who were not on VAD, exception status shows a trend toward improved waitlist survival (HR 0.843, 95% CI 0.652–1.09, p = 0.19). Conclusions: Status 1A exception patients have improved waitlist and unadjusted post‐transplant survival as compared to standard criteria patients, and are, on average, less acutely ill at listings. These findings highlight heterogeneity within Status 1A and suggest an opportunity to incorporate objective acuity measures into exception review.
- Open Access
- 15 July 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (14) , e038609
Low Burden of Arrhythmia in Pediatric Patients and Patients With Congenital Heart Disease Participating in Cardiac Rehabilitation
Background: Cardiac rehabilitation (CR) is underused in pediatric and congenital heart disease populations. Concern about arrhythmia risk may be an obstacle to CR referral. We sought to describe the frequency and risk factors for arrhythmia in patients who participated in a standardized CR program. Methods: We conducted a retrospective chart review of all patients who completed at least 1 CR encounter from 2017 to 2022 at a pediatric cardiology center. We used descriptive statistics to determine the frequency of atrial and ventricular ectopy. Logistic regression was performed to identify predictors of frequent ventricular ectopy, nonsustained ventricular tachycardia, or ventricular tachycardia. Results: There were 177 patients who participated in 4494 rehabilitation encounters over the 6‐year study period (median age, 17 years [14–22]). Most patients had congenital heart disease (63%). Moderate or severe systolic dysfunction was noted in 14% of patients. Presence of an implantable cardioverter‐defibrillator (9% of patients) and a ventricular assist device (5% of patients) was noted. Nonsustained ventricular tachycardia occurred in 7 patients (3.9%) across 18 sessions (0.4%). There was an episode of sustained ventricular tachycardia resulting in an appropriate implantable cardioverter‐defibrillator shock. There were no deaths. Patients ≥18 years old (odds ratio, 2.7 [95% CI, 1.1 – 6.4]) were more likely to have frequent ventricular ectopy, nonsustained ventricular tachycardia, or ventricular tachycardia. Conclusions: Supervised CR in pediatric and congenital heart disease populations is associated with a low risk for clinically significant arrhythmias, and should not be an obstacle to referral for individuals who would otherwise benefit from CR.
- 15 July 2025
- Published by Wolters Kluwer Health in Journal of the American Heart Association
- Vol. 14 (14) , e038609
Open AccessLow Burden of Arrhythmia in Pediatric Patients and Patients With Congenital Heart Disease Participating in Cardiac Rehabilitation
Background: Cardiac rehabilitation (CR) is underused in pediatric and congenital heart disease populations. Concern about arrhythmia risk may be an obstacle to CR referral. We sought to describe the frequency and risk factors for arrhythmia in patients who participated in a standardized CR program. Methods: We conducted a retrospective chart review of all patients who completed at least 1 CR encounter from 2017 to 2022 at a pediatric cardiology center. We used descriptive statistics to determine the frequency of atrial and ventricular ectopy. Logistic regression was performed to identify predictors of frequent ventricular ectopy, nonsustained ventricular tachycardia, or ventricular tachycardia. Results: There were 177 patients who participated in 4494 rehabilitation encounters over the 6‐year study period (median age, 17 years [14–22]). Most patients had congenital heart disease (63%). Moderate or severe systolic dysfunction was noted in 14% of patients. Presence of an implantable cardioverter‐defibrillator (9% of patients) and a ventricular assist device (5% of patients) was noted. Nonsustained ventricular tachycardia occurred in 7 patients (3.9%) across 18 sessions (0.4%). There was an episode of sustained ventricular tachycardia resulting in an appropriate implantable cardioverter‐defibrillator shock. There were no deaths. Patients ≥18 years old (odds ratio, 2.7 [95% CI, 1.1 – 6.4]) were more likely to have frequent ventricular ectopy, nonsustained ventricular tachycardia, or ventricular tachycardia. Conclusions: Supervised CR in pediatric and congenital heart disease populations is associated with a low risk for clinically significant arrhythmias, and should not be an obstacle to referral for individuals who would otherwise benefit from CR.
- 13 September 2024
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (12) , 2046-2047
Expanding the Donor Pool: Sequential Double Lung then Heart Transplant Using Ex-Vivo Normothermic Perfusion
- 13 September 2024
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (12) , 2046-2047
Expanding the Donor Pool: Sequential Double Lung then Heart Transplant Using Ex-Vivo Normothermic Perfusion
- Open Access
- 1 January 2024
- Published by Stanford University Press in Journal of Mass Spectrometry and Advances in the Clinical Lab
- Vol. 31, 1-7
Use of volumetric absorptive microsampling and parallel reaction monitoring mass spectrometry for tacrolimus blood trough measurements at home in pediatric heart transplant patients
Measurement of trough levels for calcineurin inhibitors by venipuncture sampling is a mainstay of patient management in solid organ transplant recipients but challenging in pediatric patients. Volumetric Absorptive Microsampling (VAMS) is a patient-friendly, minimally invasive sampling technique to accurately collect blood. An assay for measurement of tacrolimus in blood using VAMS, coupled with parallel reaction monitoring (PRM) mass spectrometry, was validated in pediatric heart transplant patients. Tacrolimus was measured by a newly developed high-resolution PRM assay and compared with low-resolution tandem mass spectrometry (MRM). Dried blood samples were collected from pediatric heart transplant patients (n = 35) using VAMS devices and a satisfaction survey was completed by patients/guardians. Tacrolimus concentrations were compared across whole liquid blood, dried blood spots, and capillary blood, and shipping stability determined. The PRM assay was linear over a range 1–50 ng/mL, similar to MRM but had greater specificity due to reduced background noise. No significant differences in tacrolimus concentrations were observed between VAMS and venous blood. Tacrolimus dried on VAM tips was stable for 14 days and concentrations were unaffected by postal shipping. The variability in two simultaneously collected at-home patient samples was minimal – average concentration difference was 0.12 ± 0.94 ng/mL (p = 0.6) between paired samples. A high resolution PRM mass spectrometry assay was developed for home-based dried blood collections for therapeutic monitoring of tacrolimus. The advantage of PRM was enhanced specificity and the VAMS devices provided a simple and convenient approach to blood sampling at home in pediatric heart transplant patients.
- 1 January 2024
- Published by Stanford University Press in Journal of Mass Spectrometry and Advances in the Clinical Lab
- Vol. 31, 1-7
Open AccessUse of volumetric absorptive microsampling and parallel reaction monitoring mass spectrometry for tacrolimus blood trough measurements at home in pediatric heart transplant patients
Measurement of trough levels for calcineurin inhibitors by venipuncture sampling is a mainstay of patient management in solid organ transplant recipients but challenging in pediatric patients. Volumetric Absorptive Microsampling (VAMS) is a patient-friendly, minimally invasive sampling technique to accurately collect blood. An assay for measurement of tacrolimus in blood using VAMS, coupled with parallel reaction monitoring (PRM) mass spectrometry, was validated in pediatric heart transplant patients. Tacrolimus was measured by a newly developed high-resolution PRM assay and compared with low-resolution tandem mass spectrometry (MRM). Dried blood samples were collected from pediatric heart transplant patients (n = 35) using VAMS devices and a satisfaction survey was completed by patients/guardians. Tacrolimus concentrations were compared across whole liquid blood, dried blood spots, and capillary blood, and shipping stability determined. The PRM assay was linear over a range 1–50 ng/mL, similar to MRM but had greater specificity due to reduced background noise. No significant differences in tacrolimus concentrations were observed between VAMS and venous blood. Tacrolimus dried on VAM tips was stable for 14 days and concentrations were unaffected by postal shipping. The variability in two simultaneously collected at-home patient samples was minimal – average concentration difference was 0.12 ± 0.94 ng/mL (p = 0.6) between paired samples. A high resolution PRM mass spectrometry assay was developed for home-based dried blood collections for therapeutic monitoring of tacrolimus. The advantage of PRM was enhanced specificity and the VAMS devices provided a simple and convenient approach to blood sampling at home in pediatric heart transplant patients.
- 22 August 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (1) , 32-35
Reality of DCD donor use in pediatric thoracic transplantation in the United States
- 22 August 2023
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 43 (1) , 32-35
Reality of DCD donor use in pediatric thoracic transplantation in the United States
- Open Access
Facility-based and virtual cardiac rehabilitation in young patients with heart disease during the COVID-19 era
Background: Cardiac rehabilitation (CR) is an important tool for improving fitness and quality of life in those with heart disease (HD). Few pediatric centers use CR to care for these patients, and virtual CR is rarely used. Additionally, it is unclear how the COVID-19 era has changed CR outcomes. Objectives: This study assessed fitness improvements in young HD patients participating in both facility-based and virtual CR during the COVID-19 pandemic. Methods: This retrospective single-center cohort study included new patients who completed CR from March 2020 through July 2022. CR outcomes included physical, performance, and psychosocial measures. Comparison between serial testing was performed with a paired t-test with P2 , 62.3±16.1 v 71±18.2% of predicted, p=0.0007), 6-minute walk (6MW) distance (401±163.8 v 480.7±119.2 meters, p=2 (60±15.3 v 70.2±17.8 % of predicted; p=0.002) were seen among those that completed facility-based CR; this was not observed in the virtual group. Both groups demonstrated improvement in 6MW distance, sit-to-stand repetitions, and sit-and-reach distance. Conclusions: Completion of a CR program resulted in fitness improvements during the COVID-19 era regardless of location.
Open AccessFacility-based and virtual cardiac rehabilitation in young patients with heart disease during the COVID-19 era
Background: Cardiac rehabilitation (CR) is an important tool for improving fitness and quality of life in those with heart disease (HD). Few pediatric centers use CR to care for these patients, and virtual CR is rarely used. Additionally, it is unclear how the COVID-19 era has changed CR outcomes. Objectives: This study assessed fitness improvements in young HD patients participating in both facility-based and virtual CR during the COVID-19 pandemic. Methods: This retrospective single-center cohort study included new patients who completed CR from March 2020 through July 2022. CR outcomes included physical, performance, and psychosocial measures. Comparison between serial testing was performed with a paired t-test with P2 , 62.3±16.1 v 71±18.2% of predicted, p=0.0007), 6-minute walk (6MW) distance (401±163.8 v 480.7±119.2 meters, p=2 (60±15.3 v 70.2±17.8 % of predicted; p=0.002) were seen among those that completed facility-based CR; this was not observed in the virtual group. Both groups demonstrated improvement in 6MW distance, sit-to-stand repetitions, and sit-and-reach distance. Conclusions: Completion of a CR program resulted in fitness improvements during the COVID-19 era regardless of location.
- Open Access
- 15 February 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (5) , 611-618
Mutations in latent membrane protein 1 of Epstein-Barr virus are associated with increased risk of posttransplant lymphoproliferative disorder in children
- 15 February 2023
- Published by Elsevier in American Journal of Transplantation
- Vol. 23 (5) , 611-618
Open AccessMutations in latent membrane protein 1 of Epstein-Barr virus are associated with increased risk of posttransplant lymphoproliferative disorder in children
- 2 November 2022
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 42 (3) , 345-353
Heart transplant offers are less likely to be accepted on weekends, holidays, and conferences
- 2 November 2022
- Published by Elsevier in The Journal of Heart and Lung Transplantation
- Vol. 42 (3) , 345-353
Heart transplant offers are less likely to be accepted on weekends, holidays, and conferences
- 1 June 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (3) , 557-565
Abdominal CT and MRI Findings of Portal Hypertension in Children and Adults with Fontan Circulation
Evidence of portal hypertension at CT or MRI may serve as a noninvasive surrogate for elevated Fontan pressure, helping risk-stratify patients with Fontan circulation who warrant comprehensive hemo... Background Portal hypertension in the Fontan circulation is a function of elevated systemic venous pressure and liver fibrosis. Purpose To quantify the prevalence of radiologic evidence of portal h...
- 1 June 2022
- Published by Radiological Society of North America (RSNA) in Radiology
- Vol. 303 (3) , 557-565
Abdominal CT and MRI Findings of Portal Hypertension in Children and Adults with Fontan Circulation
Evidence of portal hypertension at CT or MRI may serve as a noninvasive surrogate for elevated Fontan pressure, helping risk-stratify patients with Fontan circulation who warrant comprehensive hemo... Background Portal hypertension in the Fontan circulation is a function of elevated systemic venous pressure and liver fibrosis. Purpose To quantify the prevalence of radiologic evidence of portal h...